SOP Guide for Pharma

Analytical Method Development: SOP for Line Clearance Check Method Development – V 2.0

Analytical Method Development: SOP for Line Clearance Check Method Development – V 2.0

Standard Operating Procedure for Line Clearance Check Method Development in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/239/2025
Supersedes SOP/AMD/239/2022
Page No. Page 1 of 12
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define a systematic procedure for developing and executing line clearance checks prior to initiating analytical activities in the Analytical Method Development (AMD) laboratory to avoid

mix-ups, cross-contamination, and non-compliance.

2. Scope

This SOP applies to all equipment, instruments, and work areas within the Analytical Method Development department where testing or method development is performed.

3. Responsibilities

  • Analytical Scientist: Conducts line clearance checks and documents status prior to analysis.
  • QC/QA Officer: Reviews and verifies that clearance is complete and compliant.
  • Lab Supervisor: Approves the clearance checklist and authorizes continuation of activity.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that all equipment and workspaces are free from previous batch residues, documents, and test materials before use.

5. Procedure

5.1 Development of Line Clearance Checklist

  1. Prepare a line clearance checklist that includes:
    • Previous sample labels and remnants removed
    • Waste bins emptied and cleaned
    • Glassware cleaned and dried
    • Workbenches wiped with disinfectant
    • Instruments logged off and blank runs completed
  2. Include unique identification number for traceability (Annexure-1).

5.2 Execution of Line Clearance

  1. Ensure all documents related to previous analysis are archived.
  2. Dispose of waste media, reagents, swabs, and vials as per lab disposal SOPs.
  3. Cross-check instruments and reference standards for batch-specific setup.
  4. Fill the line clearance checklist and sign off by analyst and supervisor.

5.3 Verification and Authorization

  1. QC/QA personnel verify completion of checklist items.
  2. QA reviewer signs the checklist and permits start of analytical activity.
  3. Checklist to be filed with method validation or analysis batch record.

5.4 Re-clearance Requirement

  1. Perform re-clearance if:
    • Any deviation occurs during testing
    • Testing is interrupted for more than 8 hours
    • Any suspected mix-up is reported

5.5 Documentation and Storage

  1. Maintain clearance records for at least 3 years.
  2. Ensure all logs are traceable by equipment ID and analysis number.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • AMD: Analytical Method Development

7. Documents

  1. Line Clearance Checklist – Annexure-1
  2. Line Clearance Authorization Log – Annexure-2
  3. Deviation Report Log (if applicable) – Annexure-3

8. References

  • ICH Q9: Quality Risk Management
  • FDA Guidance for Industry: Analytical Procedures and Methods Validation
  • WHO Technical Report Series No. 986: GMP for Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Vaishali Menon Rohit Khanna Sunita Reddy
Designation Analyst QA Officer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Line Clearance Checklist

Item Status (Yes/No) Remarks
Previous labels removed Yes NA
Work area disinfected Yes Cleaned with 70% IPA
Instruments logged off Yes HPLC ID #HP-202

Annexure-2: Line Clearance Authorization Log

Date Analyst QA Reviewer Status Remarks
20/05/2025 Meena R. Rohit Khanna Approved Clearance Verified

Annexure-3: Deviation Report Log

Deviation ID Date Description Corrective Action Approved By
DEV/AMD/042/2025 18/05/2025 Residual label found Training on disposal QA Head

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Included authorization log and deviation management protocol Annual Review Sunita Reddy
10/05/2022 1.0 Initial SOP Release New SOP QA Head
Exit mobile version